Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Guiqihuoxue is a Traditional Chinese Medicine (TCM) capsule formulation primarily developed and studied by institutions like The Second Hospital of Shandong University for the treatment of various types of cervical spondylosis. The name is derived from its primary components, *Angelica sinensis* (Dang Gui) and *Astragalus membranaceus* (Huang Qi), which are traditionally used to tonify Qi and invigorate blood circulation (Huoxue). It is intended to improve local blood flow, reduce inflammation, and alleviate pain and neurological symptoms caused by cervical disc degeneration or nerve root compression. In clinical trials, it has been compared to conventional treatments such as mannitol and mecobalamin to evaluate its efficacy and safety profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on guiqihuoxue.